1.20.7 Mesenchymal Epithelial Transition Definition
Mesenchymal Epithelial Transition is a process where cancer cells switch from a mesenchymal to an epithelial state, influencing their behavior and response to treatment.
Mesenchymal Epithelial Transition Definition is the term used to describe the reverse cellular reprogramming process by which a cell that has acquired mesenchymal characteristics reestablishes epithelial features, including stable cell-cell junctions and apical-basal polarity, effectively reversing the molecular and structural changes associated with the epithelial-mesenchymal transition.
Molecular Reversal Underlying the Transition
Re-Expression of Epithelial Adhesion Molecules
The mesenchymal-epithelial transition is characterized molecularly by the re-expression of E-cadherin and other epithelial junctional proteins, restoring the capacity of cells to form stable adherens junctions with neighboring cells.
Downregulation of Mesenchymal Transcription Factors
Reversal of the mesenchymal phenotype requires downregulation of the core transcription factors, including Snail, Zeb, and Twist family members, that had previously repressed epithelial gene expression, allowing epithelial gene programs to become reactivated.
Restoration of Epithelial Cytoskeletal Organization
Cells undergoing the mesenchymal-epithelial transition shift their cytoskeletal architecture from the protrusive, front-rear organized actin networks of mesenchymal cells back toward the cortical actin organization associated with stable epithelial junctions.
Regulatory Drivers of the Reverse Transition
MicroRNA-Mediated Repression of Mesenchymal Factors
Specific microRNA families, including those targeting Zeb transcription factor transcripts, play a central regulatory role in driving the mesenchymal-epithelial transition by directly suppressing the expression of mesenchymal transcriptional drivers.
Epithelial-Promoting Transcription Factors
Transcription factors that actively promote epithelial gene expression, functioning in opposition to the mesenchymal transcriptional network, contribute to stabilizing the reestablished epithelial phenotype during the reverse transition process.
Withdrawal of Transition-Inducing Signals
Reduction or removal of the extracellular signals, such as transforming growth factor beta, that originally induced the epithelial-mesenchymal transition is frequently a prerequisite for cells to undergo the reverse mesenchymal-epithelial transition.
Physiological Contexts of the Reverse Transition
Completion of Developmental Morphogenesis
During embryonic development, cells that have undergone epithelial-mesenchymal transition to enable specific migratory events often subsequently undergo mesenchymal-epithelial transition upon reaching their developmental destination, reestablishing epithelial architecture necessary for subsequent organ formation.
Resolution of Wound Healing
Following successful wound closure, epithelial cells that had transiently acquired mesenchymal characteristics to support migration typically revert to a stable epithelial phenotype through mesenchymal-epithelial transition, restoring normal tissue barrier function.
Relevance to Cancer Cell Biology
Facilitation of Metastatic Colonization
The mesenchymal-epithelial transition has been proposed as a critical step enabling disseminated cancer cells to establish proliferative colonies at distant metastatic sites, as reversion toward an epithelial phenotype may support the cell-cell adhesion and proliferative capacity required for successful outgrowth.
Contribution to Metastatic Site Phenotype
Metastatic tumor deposits frequently display epithelial characteristics resembling the primary tumor of origin, a pattern consistent with mesenchymal-epithelial transition occurring after disseminated mesenchymal-like cells reach and colonize a distant tissue site.
Therapeutic Implications
Because mesenchymal-epithelial transition may be required for the successful establishment of metastatic colonies, this reverse process has been investigated as a potential point of therapeutic intervention, with strategies aimed at preventing this reversion explored as a means of limiting metastatic outgrowth.
Summary
The mesenchymal-epithelial transition represents the reverse cellular reprogramming process through which cells reestablish epithelial adhesion, polarity, and gene expression programs after having previously undergone the epithelial-mesenchymal transition. Its role in developmental morphogenesis, wound resolution, and the successful colonization of distant metastatic sites underscores its significance as a critical counterpart to the forward transition in both normal biology and cancer progression.